1145 related articles for article (PubMed ID: 19245155)
21. [In vitro susceptibility of Candida strains to fluconazole and amphotericin B].
Fernández Andreu CM; Martínez Machin G; Illnait Zaragozi MT; Perurena Lancha MR; Aguila Sánchez A; Galloso Brito M
Rev Cubana Med Trop; 2007; 59(2):113-8. PubMed ID: 23427444
[TBL] [Abstract][Full Text] [Related]
22. A longitudinal study of the change in resistance patterns and genetic relationship of oral Candida albicans from HIV-infected patients.
McCullough M; Hume S
J Med Vet Mycol; 1995; 33(1):33-7. PubMed ID: 7650576
[TBL] [Abstract][Full Text] [Related]
23. [Oropharyngeal candidiasis resistant to fluconazole in patients infected by HIV].
Drobacheff C; Manteaux A; Millon L; Reboux G; Barale T; Laurent R
Ann Dermatol Venereol; 1996; 123(2):85-9. PubMed ID: 8761757
[TBL] [Abstract][Full Text] [Related]
24. Emergence of non-albicans Candida species and antifungal resistance in a tertiary care hospital.
Capoor MR; Nair D; Deb M; Verma PK; Srivastava L; Aggarwal P
Jpn J Infect Dis; 2005 Dec; 58(6):344-8. PubMed ID: 16377864
[TBL] [Abstract][Full Text] [Related]
25. Activity of fluconazole against Candida albicans isolates from HIV+ patients in a digestive candidosis turkey model.
Reynes J; Mallie M; Ravisse P; Bastide JM
J Med Vet Mycol; 1992; 30(5):363-7. PubMed ID: 1469537
[TBL] [Abstract][Full Text] [Related]
26. Detection of Candida dubliniensis in oropharyngeal samples of Turkish HIV-positive patients.
Tekeli A; Koyuncu E; Dolapci I; Guven GS; Sahin GO; Uzun O
Mycoses; 2005 May; 48(3):197-201. PubMed ID: 15842337
[TBL] [Abstract][Full Text] [Related]
27. Oral Candida albicans isolates with reduced susceptibility to fluconazole in Swedish HIV-infected patients.
Chryssanthou E; Torssander J; Petrini B
Scand J Infect Dis; 1995; 27(4):391-5. PubMed ID: 8658076
[TBL] [Abstract][Full Text] [Related]
28. Susceptibility of clinical isolates of Candida species to fluconazole and detection of Candida albicans ERG11 mutations.
Xu Y; Chen L; Li C
J Antimicrob Chemother; 2008 Apr; 61(4):798-804. PubMed ID: 18218640
[TBL] [Abstract][Full Text] [Related]
29. [Antifungal drug susceptibility of Candida causing oropharyngeal candidiasis in HIV infected patients].
Dieng Y; Faye-Niang MA; Ndour-Diop A; Sow PS; Dieng T; Soumare M; Bah IB; Faye O; Diop BM; Gaye O; Ndir O; Diallo S
Dakar Med; 2001; 46(1):4-7. PubMed ID: 15773146
[TBL] [Abstract][Full Text] [Related]
30. Dynamic analysis of oral Candida carriage, distribution, and antifungal susceptibility in HIV-infected patients during the first year of highly active antiretroviral therapy in Guangxi, China.
Jiang L; Yong X; Li R; Peng Y; Liu W; Qin Q; Zhang L; Liu Z; Liang H; Tao R
J Oral Pathol Med; 2014 Oct; 43(9):696-703. PubMed ID: 24931443
[TBL] [Abstract][Full Text] [Related]
31. Species distribution and in vitro antifungal susceptibility of oral yeast isolates from Tanzanian HIV-infected patients with primary and recurrent oropharyngeal candidiasis.
Hamza OJ; Matee MI; Moshi MJ; Simon EN; Mugusi F; Mikx FH; Helderman WH; Rijs AJ; van der Ven AJ; Verweij PE
BMC Microbiol; 2008 Aug; 8():135. PubMed ID: 18694525
[TBL] [Abstract][Full Text] [Related]
32. Susceptibility of candida isolates from denture-related stomatitis to antifungal agents in vitro.
Dorocka-Bobkowska B; Konopka K
Int J Prosthodont; 2007; 20(5):504-6. PubMed ID: 17944341
[TBL] [Abstract][Full Text] [Related]
33. Species distribution and antifungal susceptibility profile of oral candida isolates from HIV-infected patients in the antiretroviral therapy era.
Costa CR; de Lemos JA; Passos XS; de Araújo CR; Cohen AJ; Souza LK; Silva Mdo R
Mycopathologia; 2006 Jul; 162(1):45-50. PubMed ID: 16830191
[TBL] [Abstract][Full Text] [Related]
34. Oropharyngeal candidiasis in head and neck cancer patients in Iran: Species identification, antifungal susceptibility and pathogenic characterization.
Jahanshiri Z; Manifar S; Moosa H; Asghari-Paskiabi F; Mahmoodzadeh H; Shams-Ghahfarokhi M; Razzaghi-Abyaneh M
J Mycol Med; 2018 Jun; 28(2):361-366. PubMed ID: 29602636
[TBL] [Abstract][Full Text] [Related]
35. In vitro susceptibility of Candida species isolated from blood culture to some antifungal agents.
Citak S; Ozçelik B; Cesur S; Abbasoğlu U
Jpn J Infect Dis; 2005 Feb; 58(1):44-6. PubMed ID: 15728993
[TBL] [Abstract][Full Text] [Related]
36. Candidemia and the susceptibility pattern of Candida isolates in blood.
Osoba AO; Al-Mowallad AW; McAlear DE; Hussein BA
Saudi Med J; 2003 Oct; 24(10):1060-3. PubMed ID: 14578968
[TBL] [Abstract][Full Text] [Related]
37. Mechanisms of resistance to fluconazole in Candida albicans clinical isolates from Iranian HIV-infected patients with oropharyngeal candidiasis.
Salari S; Khosravi AR; Mousavi SA; Nikbakht-Brojeni GH
J Mycol Med; 2016 Mar; 26(1):35-41. PubMed ID: 26627124
[TBL] [Abstract][Full Text] [Related]
38. Effect of Ethiopian multiflora honey on fluconazole-resistant Candida species isolated from the oral cavity of AIDS patients.
Mulu A; Diro E; Tekleselassie H; Belyhun Y; Anagaw B; Alemayehu M; Gelaw A; Biadglegne F; Desalegn K; Yifiru S; Tiruneh M; Kassu A; Nishikawa T; Isogai E
Int J STD AIDS; 2010 Nov; 21(11):741-5. PubMed ID: 21187354
[TBL] [Abstract][Full Text] [Related]
39. Iranian HIV/AIDS patients with oropharyngeal candidiasis: identification, prevalence and antifungal susceptibility of Candida species.
Khedri S; Santos ALS; Roudbary M; Hadighi R; Falahati M; Farahyar S; Khoshmirsafa M; Kalantari S
Lett Appl Microbiol; 2018 Oct; 67(4):392-399. PubMed ID: 30019443
[TBL] [Abstract][Full Text] [Related]
40. Fluconazole and itraconazole susceptibilities of Candida spp. isolated from oropharyngeal specimens and blood cultures of paediatric haematology/oncology patients.
Kennedy HF; Shankland GS; Bagg J; Chalmers EA; Gibson BE; Williams CL
Mycoses; 2006 Nov; 49(6):457-62. PubMed ID: 17022761
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
